Drug profile

The FDA adverse-event record for Bordetella Bronchiseptica Vaccine

247 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Bordetella Bronchiseptica Vaccine. See the species affected, top reactions, and outcomes below.

247
adverse-event reports
10.9%
death-coded share
Dog
most-reported species
113
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
247
Total Reports
27
Deaths Reported
10.9%
Death Rate

Active Ingredients

Bordetella Bronchiseptica Vaccine

Administration Routes

OralUnknownNasalParenteralSubcutaneousOther

Species Affected

Dog 247

Most Affected Breeds

Retriever - Labrador 23
Shih Tzu 15
Terrier - Yorkshire 13
Retriever - Golden 12
Dachshund (unspecified) 10
Terrier - Bull - American Pit 10
Boxer (German Boxer) 9
Shepherd Dog - German 9
Pug 7
Maltese 7

Most Reported Reactions

Vomiting 113
Lethargy (see also Central nervous system depression in 'Neurological') 71
Diarrhoea 43
Anaphylaxis 35
Facial swelling (see also 'Skin') 32
Anorexia 26
Fever 25
Pale mucous membrane 24
Other abnormal test result NOS 24
Not eating 18
Death 18
Hives (see also 'Skin') 18

Outcome Breakdown

Ongoing
110 (44.5%)
Recovered/Normal
93 (37.7%)
Died
19 (7.7%)
Outcome Unknown
17 (6.9%)
Euthanized
8 (3.2%)

Bordetella Bronchiseptica Vaccine Adverse Event Insights

247 reports name Bordetella Bronchiseptica Vaccine; 27 recorded a death outcome (10.9% of reported events, not a population-level mortality rate). Active ingredient: Bordetella Bronchiseptica Vaccine. Administration routes: Oral, Unknown, Nasal, Parenteral.

By species: Dog (247 reports). By breed: Retriever - Labrador (23), Shih Tzu (15), Terrier - Yorkshire (13).

Leading clinical signs: Vomiting (113), Lethargy (see also Central nervous system depression in 'Neurological') (71), Diarrhoea (43), Anaphylaxis (35). Outcome, 247 coded reports: Ongoing leads at 44.5%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.